glp 1 not working for me Why Weight Loss Injections Don't Work Some Patients Purchasing a GLP-1 without consulting

2535% loss rates) 11:05 What efficacy estimate really means (race-track analogy) 13:28 Real-world view: treatment-regimen estimate (2023.7%) vs trial ideal 15:40 Mechanism refresher: GIP, GLP-1, glucagon and why RETA differs from TIRZ 18:05 Side effects, dysesthesia/allodynia & who stopped treatment (BMI differences) 21:02 Why the lower doses matter & who actually needs 30% weight loss 24:15 From just make the scale go down to quality of weight loss & body composition 28:05 Future focus: health, longevity, and peptides beyond hitting goal weight 30:40 Viewer Q&A: combining RETA + TIRZ, amylin (eloralintide) combos & talk to your doctor 34:38 How retatrutide changes the next decade of obesity treatment conversations 37:22 News update: high-dose Wegovy 7.2 mg approval in the EU & US outlook 40:55 Orforglipron oral GLP-1: liver-signal concerns & fast-track FDA review 45:20 Why small-molecule oral GLP-1s arent the same as injectable peptides 48:40 New topic: Indiana Safe Drug Act of 2025 and why Dave is concerned 51:02 Production caps, essentially a copy language & shifting power from prescribers to FDA 54:28 How the bill undermines personalization while ignoring real safety tools 57:05 Safety theater vs real safeguards: API sourcing, sterility & adverse-event reporting 59:45 Who actually gets hit: compliant 503A/503B compounders vs existing bad actors 1:02:05 Call to action: petition at otplinks.com & why patient voices matter 1:05:10 Change.org impact, media attention & centering the patient perspective 1:07:30 Final Q&A, subscribe, obesity.news email list & closing thanks Visit Our Sponsors

Sethumadhavan S, Chinnakannu P: L-carnitine and alpha-lipoic acid improve age-associated decline in mitochondrial respiratory chain activity of rat heart muscle

Formulation Considerations for Cosmetic Chemists Copper Tripeptide-1 requires controlled formulation conditions to maintain stability and performance

He W, Lam TK, Obici S, et al

Adding high-fiber meals when you can barely finish half a plate is impractical

Together, they are investigated for complementary activity across multiple endocrine and systemic pathways in experimental settings